01563nas a2200229   4500000000100000008004100001260001200042653001300054653001600067653001900083653001200102100003600114700002700150700002900177700004400206700003200250245010100282856008000383300001000463490000700473520085300480       2026                            d  c03/202610aCovid-1910aCoinfection10aPublic health 10aLeprosy1 aAna Flávia Sobral de Medeiros 1 aAline Lidiane Batista 1 aSidnei Miyoshi Sakamoto 1 aDiogo Manuel Lopes de Paiva Cavalcanti 1 aRenata Ferreira Magalhães 00aImpact of the Covid-19 Pandemic on Leprosy: Evidence From an Endemic City in Northeastern Brazil  uhttps://www.scielo.br/j/rsbmt/a/4TvhLp5ncnD4m5n7FYDQvyt/?format=pdf&lang=en  a1 - 50 v593 a<p><strong>Background:</strong></p>

<p>Leprosy is endemic to Brazil. The Coronavirus disease 2019 (COVID-19) pandemic may have affected diagnosis and treatment.</p>

<p><strong>Methods:</strong></p>

<p>Study in Mossoró-RN (2018-2023) analyzing epidemiological data, treatment abandonment, and COVID-19 co-infection.</p>

<p><strong>Results:</strong></p>

<p>The average weekly number of cases declined during the post-pandemic period. The dropout rate was higher during the acute phase. Male sex was associated with dropout (odds ratio [OR], 6.32; p = 0.013). Of the 57 patients tested for COVID-19, 21 tested positive, with no clinical aggravation.</p>

<p><strong>Conclusions:</strong></p>

<p>The pandemic has affected leprosy control. Local strategies helped reduce the impact, and co-infection did not worsen the disease</p>